Status:
RECRUITING
Application of a Protocol of Personalized Medicine in Patients With Type 2 Diabetes Mellitus and Multiple Doses of Insulin in Routine Clinical Care
Lead Sponsor:
Hospital Arnau de Vilanova
Collaborating Sponsors:
Institut Catala de Salut
Conditions:
Type 2 Diabetes Mellitus
Multiple Dose Insulin Therapy
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to test a protocol of personalized medicine in routine clinical practice in people with type 2 diabetes (T2DM) treated with multiple dose insulin injections (MD...
Detailed Description
An algorithm will be applied in which, depending on the presence/absence of pancreatic autoimmunity and the estimation of pancreatic reserve, the same treatment will be maintained and CGM (continuous ...
Eligibility Criteria
Inclusion
- Type 2 diabetes treated with multiple dose insulin therapy
Exclusion
- Gestation or planning gestation in the following 12 months
- Glucocorticoid use for an acute condition
- Transient insulinisationt (less than 6 months)
- Any condition that prevents the patient or their caregiver from following up for 6 months
- Severe mental illness
- Drug or alcohol abuse
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
239 Patients enrolled
Trial Details
Trial ID
NCT06148376
Start Date
November 1 2023
End Date
December 31 2025
Last Update
June 24 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitari Arnau de Vilanova
Lleida, Spain, 25198
2
Centres Atenció Primària Lleida, Alt Pirineu i Aran
Lleida, Spain